$SIGA News
Last published 2d ago
- 2d agoSIGASIGA Technologies Third Quarter 2026 Earnings Call - SIGA TECHNOLOGIES INCEarnings Call TranscriptsWelcome to the SEGA Business Update Call. Before we turn the call over to SEGA management, please note that any forward-looking statements made during this call are based on management's current expectations and observat
- 2d agoSIGASIGA TECHNOLOGIES INC - EXHIBIT 99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2d agoSIGASIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026GlobeNewswireAwarded $15 Million Procurement Contract from Canadian Department of National Defence for Oral TPOXX in October Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA
- 2d agoSIGASIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.GlobeNewswireConcludes 30-Year Tenure Leading Development of TPOXX®, the First FDA-Approved Antiviral for the Treatment of Smallpox
- 2d agoSIGASIGA Announces Retirement of Chief Scientific Officer Dennis Hruby, Ph.D.GlobeNewswireNEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies (NASDAQ:SIGA), a commercial stage pharmaceutical company, announced today that Dennis Hruby, Ph.D., Executive Vice President and Chief Scientific Officer,
- 2d agoSIGASIGA Reports Financial Results for Three and Nine Months Ended September 30, 2026GlobeNewswireNEW YORK, Nov. 09, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30, 2026.
- 2w agoSIGASIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial ResultsGlobeNewswireNEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 2w agoSIGASIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®GlobeNewswireNEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that Public Services and Procurement Canada (PSPC) has awarded SIGA
- 3mo agoSIGASIGA Technologies Second Quarter 2026 Earnings Call - SIGA TECHNOLOGIES INCEarnings Call TranscriptsWelcome to SIGA Business Update Call. Before we turn the call over to Siga Management, please note that any forward-looking statements made during this call are based on management's current expectations and observations
- 3mo agoSIGASIGA Reports Financial Results for Three and Six Months Ended June 30, 2026GlobeNewswire$37 Million of TPOXX Sales Generated in the Second QuarterCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a
- 3mo agoSIGASIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial ResultsGlobeNewswireNEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 6mo agoSIGASIGA Technologies First Quarter 2026 Earnings CallSIGA TECHNOLOGIES INCEarnings Call TranscriptsWelcome to the SEGA Business Update Call. Before we turn the call over to SEGA Management, please note that any forward-looking statements made during this call are based on Management's current expectations and observat
- 6mo agoSIGASIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business UpdateGlobeNewswireOn Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second QuarterExpect to Deliver $26 Million of IV TPOXX to the U.S. Government Strategic National Stockpile by End of the Third Quarter
- 6mo agoSIGASIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial ResultsGlobeNewswireNEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 7mo agoSIGASIGA Declares Special Cash Dividend of $0.60 Per ShareGlobeNewswireNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of
- 8mo agoSIGASIGA Technologies Fourth Quarter 2025 Earnings CallSIGA TECHNOLOGIES INCEarnings Call TranscriptsWelcome to the SIGA Business Update Call. Before we turn the call over to SIGa Management, please note that any forward-looking statements made during this call are based on management's current expectations and observat
- 8mo agoSIGASIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business UpdateGlobeNewswireGenerated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026
- 8mo agoSIGASIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial ResultsGlobeNewswireNEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 1y agoSIGASIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025GlobeNewswireNEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and nine months ended September 30,
- 1y agoSIGASIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 ResultsGlobeNewswireNEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 1y agoSIGASIGA Technologies, Inc. (SIGA) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSIGASIGA Reports Financial Results for Three and Six Months Ended June 30, 2025GlobeNewswireNEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30Awarded Additional Development Funding of $27 million under the BARDA 19C Contract during the
- 1y agoSIGASIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 ResultsGlobeNewswireNEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 1y agoSIGASIGA Reports Financial Results for Three Months Ended March 31, 2025GlobeNewswireReceived $26 Million IV TPOXX Procurement Order from the U.S. Government in March$94 million in TPOXX Orders (to be Delivered to U.S. Strategic National Stockpile) outstanding as of March 31, 2025Corporate Update
- 1y agoSIGASIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 ResultsGlobeNewswireNEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 1y agoSIGASIGA Declares Special Cash Dividend of $0.60 Per ShareGlobeNewswireNEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of
- 1y agoSIGASIGA Appoints Retired General John M. Keane to its Board of DirectorsGlobeNewswireNEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, announced today the appointment of Retired United States Army General John "Jack"
- 1y agoSIGASIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024GlobeNewswireIncreased Product Sales to $133 Million in 2024Generated Pre-tax Operating Income and Net Income of $70 Million and $59 Million, Respectively, in 2024Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March
- 1y agoSIGASIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial ResultsGlobeNewswireNEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 1y agoSIGATEPOXX (tecovirimat) Approved in Japan for the Treatment of OrthopoxvirusesGlobeNewswireRegulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno Pharma Co., Ltd. engaged as exclusive distributor to supply TEPOXX
- 1y agoSIGAInterim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox AnnouncedGlobeNewswireInterim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy stopped enrolling patients in all study armsResults affirm
- 2y agoSIGASIGA Technologies, Inc. (SIGA) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSIGASIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024GlobeNewswireProduct Revenues for the Three and Nine months Ended September 30, 2024 were $9 million and $53 million, respectivelyReceived $122 Million of Procurement Orders from the U.S. Government in the Third QuarterCorporate
- 2y agoSIGASIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial ResultsGlobeNewswireNEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 2y agoSIGAWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities lawsPR NewswireWolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...
- 2y agoSIGASIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal AntibodiesGlobeNewswireNEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced that it entered into an agreement
- 2y agoSIGAWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities lawsGlobeNewswireNEW YORK, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating
- 2y agoSIGASIGA Announces Agreement to Supply TPOXX® in MoroccoGlobeNewswireNEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced that it entered into an agreement
- 2y agoSIGAKirby McInerney LLP Announces Investigation of Shareholder Claims Against SIGA Technologies, Inc. (SIGA)Business WireThe law firm of Kirby McInerney LLP is investigating potential claims against SIGA Technologies, Inc. ("SIGA" or the "Company") (NASDAQ:SIGA). The investigation concerns whether SIGA and/or certain of its officers have
- 2y agoSIGAWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities lawsPR NewswireWolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...
- 2y agoSIGAWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities lawsPR NewswireWolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is...
- 2y agoSIGASIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®GlobeNewswireNEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract with the U.S.
- 2y agoSIGATopline Results from PALM 007 Study of SIGA's Tecovirimat in Treatment of Mpox ReleasedGlobeNewswirePreliminary analysis shows the study did not reach statistical significance on its primary endpoint of tecovirimat being superior to placebo in lesion resolution for all patientsResults suggest tecovirimat provides
- 2y agoCMRXNNVCSIGAVERURapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs MarketGlobeNewswirePALM BEACH, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - The demand for antiviral drugs has been increasing globally due to the growing prevalence of viral diseases. Customers are
- 2y agoRTXLMTSIGAHONContracts for Aug. 2, 2024U.S. Department of WarNAVY Raytheon Co., Tucson, Arizona, was awarded a $159,900,991 firm-fixed-price contract for MK 15 Close-In Weapon System upgrades and conversions, system overhauls, MK 15 Mod 31 SeaRAM upgrade kits and conversions and associated hardware. Work will be performed in Louisville, Kentucky (27%); El Segundo, California (15%); Tucson, Arizona (14%); Williston, Vermont (6%); Tempe, Arizona (4%); Ottobru ...
- 2y agoSIGASIGA Technologies, Inc. (SIGA) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSIGASIGA Reports Financial Results for Three and Six Months Ended June 30, 2024GlobeNewswireGenerated Product Sales of $21 Million in the Second Quarter, and $45 Million in the Six Months Ended June 30, 2024Received $113 Million Procurement Order from U.S. Government for Oral TPOXX in JulyCorporate Update
- 2y agoSIGASIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial ResultsGlobeNewswireNEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a
- 2y agoSIGASIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®GlobeNewswireNEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised a
- 2y agoSIGASIGA Announces Agreement to Sell TPOXX® to ASEAN Member StatesGlobeNewswireNEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to expand access to TPOXX